Bariatric Metabolic Surgery vs Glucagon|Like Peptide|1 Receptor ...

Bariatric Surgery vs Glucagon-Like Peptide-1 Receptor Agonists ...

Findings In this cohort study comprising 6070 patients, among individuals with a diabetes duration of 10 years or less, BMS was associated with ...

Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor ...

In this cohort study, BMS was associated with greater reduced mortality compared with first-generation GLP-1RAs among individuals with a ...

Effectiveness of bariatric metabolic surgery versus glucagon-like ...

In patients with obesity and diabetes, both bariatric metabolic surgery (BMS) and treatment with glucagon-like peptide-1 (GLP-1) receptor ...

Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor ...

This study suggests that BMS was associated with greater reduced mortality compared with GLP-1RAs among individuals with a diabetes duration of 10 years or ...

Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists ...

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) semaglutide and liraglutide as antiobesity medications has surged in recent ...

Bariatric metabolic surgery more effective than GLP1R agonists in ...

Bariatric surgery was associated with a 57% lower risk of the incidence of first-ever congestive HF compared with GLP1R agonists.

Study Finds Bariatric Surgery Declined with Rise in GLP-1 Drugs to ...

Tsai notes that while GLP-1 RAs can effectively treat obesity and related conditions (such as diabetes), these medications have been limited by ...

Adverse event comparison between glucagon‐like peptide‐1 ...

GLP-1RA AOMs do not appear to lead to a heightened risk of AEs in patients who have previously undergone bariatric surgery. While our study ...

Weighing the Options: Bariatric Surgery vs. Weight Loss Drugs

Recent studies favor bariatric surgery for overall weight loss and Body Mass Index (BMI) reduction, but show that both surgery and GLP-1 ...

Both GLP-1 Receptor Agonists and Bariatric Surgery Lower the Risk ...

When compared with those who received no treatment, the researchers found that patients who received a GLP-1 RA had a 39% lower risk of ...

Cardiovascular and diabetes outcomes among patients with obesity ...

Compared with glucagon-like peptide 1 receptor agonist treatment, metabolic bariatric surgery is associated with superior metabolic outcomes and ...

Bariatric Surgery Is More Cost Effective Than Newer Weight Loss ...

Long term, the cost effectiveness of bariatric surgery is greater than that of GLP-1 RA weight loss drugs alone, but a combination of the two ...

What Is Best for Weight Loss? A Comparative Review of the Safety ...

When choosing between bariatric surgery and semaglutide, individual factors and preferences should be considered. Bariatric surgery offers high ...

Bariatric surgery more effective than GLP-1 agonist weight loss ...

Weight-loss surgery produces greater and more durable weight loss than glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and lifestyle interventions, a ...

Glucagon-like peptide-1 receptor agonists for post-bariatric surgery ...

Weight regain and insufficient weight loss are common challenges found after bariatric surgery. · There has not been an established standard therapy for managing ...

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 ...

For patients with a diabetes duration of 10 years or less (2,371 pairs), mortality was considered lower for individuals who underwent BMS than ...

A Comparison of Bariatric Metabolic Surgery and Novel Incretin ...

Recently, novel incretin-based therapies targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors have gained ...

Weight loss between glucagon‐like peptide‐1 receptor agonists and ...

In adults with obesity, bariatric surgery still confers the highest reductions in weight and BMI but confers similar effects in glycemic control ...

Bariatric Surgery Beats GLP-1 RAs in Reducing Mortality Risk

Bariatric metabolic surgery (BMS) offers a survival advantage over glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in adults with obesity and diabetes ...

Role of GLP-1 in the Metabolic Success of Bariatric Surgery

The increase in endogenous GLP-1 signaling has been considered a primary pathway leading to postsurgical weight loss and improvements in glucose ...